Animal & Veterinary

FDA Approves First Insulin Product for Use with Automatic Injection Pen in Cats and Dogs

Approval provides consumers with additional option for insulin delivery

March 19, 2014

Media Inquiries: Megan Bensette, 240-506-6818
Consumer Inquiries: 240-276-9300, AskCVM@fda.hhs.gov

The Food and Drug Administration (FDA) today announced the first approval of an insulin for use in cats and dogs via an automatic injection pen. Vetsulin, a porcine insulin, may now be used with the VetPen automatic injection pen. The approval provides consumers with the option of using Vetsulin with the refillable VetPen, which automatically measures out the prescribed insulin dose.

In 2011, Vetsulin was taken off the market due to manufacturing concerns. The product was reintroduced to the market in 2013 and FDA continues to monitor its use.

Federal law restricts this drug to use by or on the order of a licensed veterinarian. The most common side effect experienced with Vetsulin is hypoglycemia (low blood sugar).

Vetsulin is manufactured by Intervet, Inc. For questions on how to obtain Vetsulin, please contact Merck Animal Health Customer Service at 1-800-521-5767.

Contact FDA

240-276-9300
240-276-9115 FAX
Issued by: FDA, Center for Veterinary Medicine

Communications Staff, HFV-12

7519 Standish Place

Rockville, MD 20855

Page Last Updated: 06/05/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.